These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
825 related items for PubMed ID: 8609172
1. Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican. Steinfeld R, Van Den Berghe H, David G. J Cell Biol; 1996 Apr; 133(2):405-16. PubMed ID: 8609172 [Abstract] [Full Text] [Related]
8. Heparin-induced overexpression of basic fibroblast growth factor, basic fibroblast growth factor receptor, and cell-associated proteoheparan sulfate in cultured coronary smooth muscle cells. Skaletz-Rorowski A, Schmidt A, Breithardt G, Buddecke E. Arterioscler Thromb Vasc Biol; 1996 Aug 27; 16(8):1063-9. PubMed ID: 8696947 [Abstract] [Full Text] [Related]
9. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor. Aviezer D, Levy E, Safran M, Svahn C, Buddecke E, Schmidt A, David G, Vlodavsky I, Yayon A. J Biol Chem; 1994 Jan 07; 269(1):114-21. PubMed ID: 8276782 [Abstract] [Full Text] [Related]
10. Expression of syndecan-2, -4, and fibroblast growth factor receptor type 1 in human periodontal ligament fibroblasts and down-regulation of these membrane proteins during maturation in culture. Shimazu A, Bachchu MA, Morishita M, Noshiro M, Kato Y, Iwamoto Y. J Dent Res; 1999 Dec 07; 78(12):1791-9. PubMed ID: 10598908 [Abstract] [Full Text] [Related]
11. Basic fibroblast growth factor binding and processing by human glioma cells. Murphy PR, Knee RS. Mol Cell Endocrinol; 1995 Oct 30; 114(1-2):193-203. PubMed ID: 8674845 [Abstract] [Full Text] [Related]
12. Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2. Kato M, Wang H, Kainulainen V, Fitzgerald ML, Ledbetter S, Ornitz DM, Bernfield M. Nat Med; 1998 Jun 30; 4(6):691-7. PubMed ID: 9623978 [Abstract] [Full Text] [Related]
14. Acidic and basic fibroblast growth factor bind with differing affinity to the same heparan sulfate proteoglycan on BALB/c 3T3 cells: implications for potentiation of growth factor action by heparin. Brown KJ, Hendry IA, Parish CR. J Cell Biochem; 1995 May 30; 58(1):6-14. PubMed ID: 7543903 [Abstract] [Full Text] [Related]
16. Basic fibroblast growth factor (bFGF) dissociates rapidly from heparan sulfates but slowly from receptors. Implications for mechanisms of bFGF release from pericellular matrix. Moscatelli D. J Biol Chem; 1992 Dec 25; 267(36):25803-9. PubMed ID: 1464594 [Abstract] [Full Text] [Related]
17. Syndecan, a developmentally regulated cell surface proteoglycan that binds extracellular matrix and growth factors. Bernfield M, Sanderson RD. Philos Trans R Soc Lond B Biol Sci; 1990 Mar 12; 327(1239):171-86. PubMed ID: 1969657 [Abstract] [Full Text] [Related]
18. Evidence that both receptor- and heparan sulfate proteoglycan-bound basic fibroblast growth factor are internalized by cultured immature Leydig cells. Murono EP, Washburn AL, Goforth DP, Wu N. Mol Cell Endocrinol; 1993 Dec 12; 98(1):81-90. PubMed ID: 8143917 [Abstract] [Full Text] [Related]
19. Heparan sulfate proteoglycan and FGF receptor target basic FGF to different intracellular destinations. Reiland J, Rapraeger AC. J Cell Sci; 1993 Aug 12; 105 ( Pt 4)():1085-93. PubMed ID: 8227197 [Abstract] [Full Text] [Related]
20. Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA. Aviezer D, Iozzo RV, Noonan DM, Yayon A. Mol Cell Biol; 1997 Apr 12; 17(4):1938-46. PubMed ID: 9121441 [Abstract] [Full Text] [Related] Page: [Next] [New Search]